Back to top
more

Phibro Animal Health Corporation (PAHC)

(Delayed Data from NSDQ)

$22.62 USD

22.62
351,040

-0.21 (-0.92%)

Updated Mar 5, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.41%
2Buy17.88%
3Hold9.48%
4Sell5.03%
5Strong Sell1.87%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 254)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for PAHC More Info

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Phibro Animal Health Corporation falls in the month of June.

All items in Millions except Per Share data.

6/30/2020 6/30/2019 6/30/2018 6/30/2017 6/30/2016
Assets          
Cash & Equivalents 91 82 79 56 34
Receivables 127 159 136 126 124
Notes Receivable 0 0 0 0 0
Inventories 197 198 178 161 168
Other Current Assets 37 27 22 21 18
Total Current Assets 452 466 415 364 343
Net Property & Equipment 148 140 130 127 127
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 124 75 79 79 81
Deposits & Other Assets 60 45 47 54 59
Total Assets 784 727 672 623 610
Liabilities & Shareholders Equity 6/30/2020 6/30/2019 6/30/2018 6/30/2017 6/30/2016
Notes Payable 0 0 0 0 0
Accounts Payable 66 73 60 57 60
Current Portion Long-Term Debt 19 13 13 6 3
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 72 69 71 53 46
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 157 154 143 116 109
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 368 314 300 307 350
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 70 43 44 50 61
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 596 511 487 472 520
Shareholders Equity 6/30/2020 6/30/2019 6/30/2018 6/30/2017 6/30/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 136 133 130 124 118
Retained Earnings 183 169 132 83 34
Other Equity -130 -86 -76 -55 -62
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 188 216 185 151 90
Total Liabilities & Shareholder's Equity 784 727 672 623 610
Total Common Equity 188 216 185 151 90
Shares Outstanding 40.40 40.40 40.30 39.80 39.40
Book Value Per Share 4.66 5.35 4.59 3.80 2.30

Fiscal Year End for Phibro Animal Health Corporation falls in the month of June.

All items in Millions except Per Share data.

12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Assets          
Cash & Equivalents 96 92 91 82 75
Receivables 126 125 127 152 147
Notes Receivable 0 0 0 0 0
Inventories 213 206 197 177 194
Other Current Assets 42 41 37 28 29
Total Current Assets 477 464 452 438 445
Net Property & Equipment 150 147 148 143 145
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 119 121 124 126 128
Deposits & Other Assets 57 57 60 69 70
Total Assets 804 790 784 776 788
Liabilities & Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 63 63 66 68 58
Current Portion Long-Term Debt 22 20 19 17 16
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 82 78 72 76 73
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 167 161 157 161 147
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 365 378 368 350 357
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 58 70 70 66
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 590 597 596 581 571
Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 137 136 136 135 134
Retained Earnings 198 191 183 182 174
Other Equity -122 -134 -130 -122 -91
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 213 192 188 195 217
Total Liabilities & Shareholder's Equity 804 790 784 776 788
Total Common Equity 213 192 188 195 217
Shares Outstanding 40.40 40.40 40.40 40.40 40.40
Book Value Per Share 5.28 4.76 4.66 4.84 5.38